Showing results (111-120 of 341) with videos related to

Sort By:
Pageof 35
Epidemiology (Cambridge, Mass.)|December 1, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationJan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.
BMJ (Clinical Research Ed.)|October 8, 2004
Issues in the reporting of epidemiological studies: a survey of recent practiceStuart J Pocock, Timothy J Collier, Kimberley J Dandreo, et al.
Gaceta Sanitaria|March 3, 2009
[Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]Jan P Vandenbroucke, Erik Von Elm, Douglas G Altman, et al.
Annals of Internal Medicine|October 17, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationJan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.
Lancet (London, England)|June 9, 2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Environmental Health Perspectives|February 3, 2004
Effect of succimer on growth of preschool children with moderate blood lead levelsKaren E Peterson, Mikhail Salganik, Carla Campbell, et al.
Circulation|October 9, 2012
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizationsJennifer K Rogers, John J V McMurray, Stuart J Pocock, et al.
European Journal of Heart Failure|June 27, 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trialLuca Monzo, Nicolas Girerd, Kevin Duarte, et al.
European Journal of Heart Failure|May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.
American Heart Journal|December 25, 2015
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialsJosephine Warren, Roxana Mehran, Usman Baber, et al.
Pageof 35